Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(15 sites)
United States
Florida Cancer Specialists - Lake Nona, Orlando, Florida Massachusetts General Hospital, Boston, Massachusetts Mayo Rochester, Rochester, Minnesota Washington Univ. School of Medicine, St Louis, Missouri Nebraska Cancer Specialists, Omaha, Nebraska Carolina BioOncology Institute, Huntersville, North Carolina UH Cleveland Medical Center, Cleveland, Ohio Sarah Cannon Nashville, Nashville, Tennessee NEXT Oncology, Austin, Texas MD Anderson Cancer Center, Houston, Texas START Center for Cancer Research, San Antonio, Texas START Center for Cancer Research, West Valley City, Utah NEXT Oncology, Fairfax, Virginia Froedtert & MCW Cancer Center, Milwaukee, Wisconsin Puerto Rico
PanOncology Trials, San Juan